Dietary fat and early-onset prostate cancer risk. 2010

Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK. alopha2003@yahoo.co.uk

The UK incidence of prostate cancer has been increasing in men aged < 60 years. Migrant studies and global and secular variation in incidence suggest that modifiable factors, including a high-fat diet, may contribute to prostate cancer risk. The aim of the present study was to investigate the role of dietary fat intake and its derivatives on early-onset prostate cancer risk. During 1999-2004, a population-based case-control study with 512 cases and 838 controls was conducted. Cases were diagnosed with prostate cancer when < or = 60 years. Controls were sourced from UK GP practice registers. A self-administered FFQ collected data on typical past diet. A nutritional database was used to calculate daily fat intake. A positive, statistically significant risk estimate for the highest v. lowest quintile of intake of total fat, SFA, MUFA and PUFA was observed when adjusted for confounding variables: OR 2.53 (95 % CI 1.72, 3.74), OR 2.49 (95 % CI 1.69, 3.66), OR 2.69 (95 % CI 1.82, 3.96) and OR 2.34 (95 % CI 1.59, 3.46), respectively, with all P for trend < 0.001. In conclusion, there was a positive statistically significant association between prostate cancer risk and energy-adjusted intake of total fat and fat subtypes. These results potentially identify a modifiable risk factor for early-onset prostate cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004034 Diet Surveys Systematic collections of factual data pertaining to the diet of a human population within a given geographic area. Diet Survey,Survey, Diet,Surveys, Diet
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
March 1999, Journal of the National Cancer Institute,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
October 1995, Journal of the National Cancer Institute,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
October 1999, Journal of the National Cancer Institute,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
March 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
October 1999, Journal of the National Cancer Institute,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
February 2004, The Journal of urology,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
May 1995, Journal of the National Cancer Institute,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
October 1993, Journal of the National Cancer Institute,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
August 1999, Cancer causes & control : CCC,
Artitaya Lophatananon, and Jane Archer, and Douglas Easton, and Richard Pocock, and David Dearnaley, and Michelle Guy, and Zsofia Kote-Jarai, and Lynne O'Brien, and Rosemary A Wilkinson, and Amanda L Hall, and Emma Sawyer, and Elizabeth Page, and Jo-Fen Liu, and Sandra Barratt, and Aneela A Rahman, and , and , and Rosalind Eeles, and Kenneth Muir
April 1998, The Journal of urology,
Copied contents to your clipboard!